KAZIA THERAPEUTICS-SPON ADR (KZIA)

US48669G1058 - ADR

0.37  0 (0%)

After market: 0.3887 +0.02 (+5.05%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-6-30)
2022
(2022-6-30)
2021
(2021-6-30)
2020
(2020-6-30)
2019
(2019-6-30)
Revenue
22.56K2.09K15.22M65.91K99.62K
Minority Interest Expense
N/AN/AN/AN/AN/A
Operating Expenses
24.15M25.38M21.56M12.20M8.82M
Research and Development
15.56M20.17M14.54M9.49M6.48M
Selling, General, and Administrative Expenses
8.58M5.23M7.02M3.69M3.79M
Operating Income
-24.12M-25.38M-6.34M-12.13M-8.72M
Interest Income/Expense
N/AN/A0.00-163.18K-1.81M
Other Income/Expense
560.000.002.19K2.26K24.93K
Non Recurring Items
3.39M0.00-2.57M-474.56K-62.73K
Income Before Taxes
-20.74M-25.38M-8.91M-12.77M-10.57M
Income Tax
-271.09K-368.08K-484.35K-298.20K-298.20K
Net Income
-20.47M-25.01M-8.42M-12.47M-10.27M
EBITDA
N/AN/AN/A-11.05M-7.64M
 
Per Share Data
EPS Diluted Total Ops
-0.94-1.60-0.61-1.38-1.45
 
Statistics
Profit Margin
-90714.45%-1196844.98%-55.32%-18915.90%-10309.44%
Operating Profit Margin
-106934.97%-1214456.46%-41.63%-18404.14%-8754.34%

All data in AUD

Charts